Danaher Co. (NYSE:DHR) Receives $264.40 Consensus Price Target from Analysts

Danaher Co. (NYSE:DHR) has received a consensus recommendation of “Moderate Buy” from the twenty ratings firms that are covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $264.40.

DHR has been the topic of a number of research analyst reports. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 22nd. Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research note on Friday, March 14th. The Goldman Sachs Group dropped their price target on Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 23rd. Finally, Jefferies Financial Group lowered their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research note on Tuesday, April 22nd.

Insider Activity at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Gilbert & Cook Inc. lifted its holdings in Danaher by 2.5% during the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after buying an additional 42 shares in the last quarter. Grimes & Company Inc. boosted its holdings in Danaher by 0.6% in the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock valued at $1,696,000 after acquiring an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA increased its position in Danaher by 16.4% in the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after purchasing an additional 45 shares during the period. Spinnaker Trust raised its holdings in Danaher by 1.2% during the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock worth $988,000 after purchasing an additional 50 shares during the last quarter. Finally, Fortis Capital Advisors LLC boosted its stake in shares of Danaher by 1.3% in the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock valued at $914,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

NYSE DHR opened at $189.42 on Friday. Danaher has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The stock’s 50-day moving average is $198.39 and its two-hundred day moving average is $219.46. The firm has a market cap of $135.56 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. On average, analysts anticipate that Danaher will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.68%. Danaher’s dividend payout ratio (DPR) is currently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.